Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51.4M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
48.7M
-
Shares change
-
+11.9M
-
Total reported value, excl. options
-
$1.54B
-
Value change
-
+$392M
-
Put/Call ratio
-
1.01
-
Number of buys
-
98
-
Number of sells
-
-48
-
Price
-
$31.60
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2023
178 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock as of Q3 2023.
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.7M shares
of 51.4M outstanding shares and own 94.82% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (6.47M shares), BVF INC/IL (4.37M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.96M shares), NEA Management Company, LLC (2.19M shares), BlackRock Inc. (2.11M shares), JANUS HENDERSON GROUP PLC (1.92M shares), Rock Springs Capital Management LP (1.82M shares), CITADEL ADVISORS LLC (1.72M shares), VANGUARD GROUP INC (1.69M shares), and STATE STREET CORP (1.62M shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.